The global glucosamine market is expected to grow by USD 229.19 million during 2020-2024, according to the latest market research report by Technavio, progressing at a CAGR of more than 6% during the forecast period. The market is driven by factors such as increasing use of combination therapy, popularity of e-commerce in the healthcare industry, and rising geriatric population.Request a free sample report
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191218005512/en/
Technavio has announced its latest market research report titled global glucosamine market 2020-2024. (Graphic: Business Wire)
The market research report segments the glucosamine market by application (arthritis and other applications) and geography (Asia, Europe, North America, and ROW).
Glucosamine Application Outlook (Revenue, USD Million, 2020-2024)
- Other applications
Glucosamine finds a large number of applications in the arthritis segment. The market is witnessing a shift toward the use of nutrachemicals and dietary supplements such as glucosamine to treat arthritis without side effects. Globally, the geriatric population is increasing significantly, leading to a prevalence of arthritis as the cartilage is more susceptible to wear with age. These factors are boosting the growth opportunities for market participants in the arthritis segment.
Glucosamine Regional Outlook (Revenue, USD Million, 2020-2024)
- North America
North American region led the market in 2019, followed by Europe, Asia, and ROW, respectively. During the forecast period, the North American region will continue to dominate as the largest market for glucosamine. This is due to the increasing sales of OTC glucosamine products and the rising prevalence of joint-related indications such as osteoarthritis. The expansion of the geriatric population in the region is also contributing to the growth of the glucosamine market.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Major Five Genetic Testing Companies:
Blackmores Ltd., Cargill Inc., Ethical Naturals Inc., GNC Holdings Inc., and Herbs Nutriproducts Pvt. Ltd. are among the vendors who have a strong position in the global market.
Blackmores Ltd. operates the business across segments such as Australia and New Zealand, China, Other Asia, and BioCeuticals Group. Glucosamine Fish Oil, Glucosamine Sulfate 1500 One-A-Day, Glucosamine Sulfate Complex 1000, Joint Formula Advanced, Joint Formula with Glucosamine Chondroitin, and Vegetarian Glucosamine Sulfate Complete 1000 are some of the key offerings of the company.
Cargill Inc. operates the business across segments such as Animal nutrition and protein, Animal nutrition and protein, Food ingredients and applications, Origination and processing, and Industrial and financial services. Regenasure is one of the key offerings of the company. It is glucosamine hydrochloride synthesized from corn. It is available in the form of a granular powder and is certified for Kosher Pareve, Kosher for Passover, and Halal use.
Ethical Naturals Inc.
Ethical Naturals Inc. operates the business through its Unified business segment. GreenGrown, which is glucosamine hydrochloride synthesized from vegetarian sources, is one of the key offerings of the company. It is available in the form of granular powder and can be used for improving joint health.
GNC Holdings Inc.
GNC Holdings Inc. operates the business across segments such as the US and Canada, International, and Manufacturing Wholesale. GNC GLUCOSAMINE 1000 MG, GNC MSM-GLUCOSAMINE, GNC GLUCOSAMINE SULFATE 500 MG, DOCTOR'S BEST, and GNC TRIPLE STRENGTH GLUCOSAMINE CHONDROITIN are some of the key offerings of the company.
Herbs Nutriproducts Pvt. Ltd.
Herbs Nutriproducts Pvt. Ltd. operates the business across segments such as Natural infusion tea, Cold pressed oils, Functional foods, Vitamins and supplements, and Beauty. Glucosamine Chondroitin Complex with Herbal Extracts is one of the key offerings of the company. It is a combination of glucosamine sulfate and chondroitin available in the form of tablets.
Technavio provides a free sample report which contains multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200